IKT
Inhibikase Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Inhibikase Therapeutics (IKT) Stock: Buy, Sell, or Hold?
$1.52
-0.01 (-0.65%)
âŧ
5d:
+1.33%
30d:
-16.94%
90d:
-36.4%
Open in Live Scanner
70/30 Portfolio Builder
Last Earnings: Nov 13, 2026
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
48/100
Position
SLIGHTLY LOW
30-Day Fair Range
$1.51 â $1.79
Position: SLIGHTLY LOW
Forward P/E & Valuation
-3.7x
Next 12M consensus est.
Wall Street Target
$6.00
+294.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.43 / $1.73
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: IKT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When IKT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: IKT is currently trading at $1.52, which is considered slightly low relative to its 30-day fair value range of $1.51 to $1.79.
Technical Outlook: Technically, IKT is in a strong downtrend. Immediate support is located at $1.43, while resistance sits at $1.73.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $6.00 (+294.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IKT is in a strong downtrend. Immediate support is located at $1.43, while resistance sits at $1.73.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $6.00 (+294.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.51 -
$1.79
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$1.51 -
$1.79
Current vs Trading Range
SLIGHTLY LOW
Support Level
$1.43
Resistance Level
$1.73
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (57/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 294.7% below Wall St target ($6.00)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-3.73
Wall Street Target
$6.00
(+294.7%)
Revenue Growth (YoY)
-100.0%
Share IKT Analysis
Share this live IKT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IKT)
Bullish
3 Retail Mentions
Reddit / WSB Comments
2
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Aug 5, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message was posted with no accompanying news articles, indicating a positive sentiment among traders regarding $IKT.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 15, 2026 9:27 PM ET
Data refreshes hourly during market hours. Next update: 10:27 PM
Data refreshes hourly during market hours. Next update: 10:27 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IKT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
24 analysts |
$1147 | 33 SELL |
|
DNTH
Dianthus Therapeutics InâĻ |
STRONG BUY
18 analysts |
$139 | 35 SELL |
|
ARDX
Ardelyx Inc |
STRONG BUY
11 analysts |
$13 | 69 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
17 analysts |
$14 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IKT Research Pages
Part B: Tradestie Flagship Market Scanners